APA (7th ed.) Citation

L, F., G, R., DA, H., JM, D., & MJ, S. (2022). Evaluating the Risk of Developing Thrombocytopenia Within Five Days of Continuous Renal Replacement Therapy Initiation in Septic Patients. Journal of pharmacy practice, 35(1), 94. https://doi.org/10.1177/0897190020959175

Chicago Style (17th ed.) Citation

L, Fay, Rechner-Neven G, Hammond DA, DeMott JM, and Sullivan MJ. "Evaluating the Risk of Developing Thrombocytopenia Within Five Days of Continuous Renal Replacement Therapy Initiation in Septic Patients." Journal of Pharmacy Practice 35, no. 1 (2022): 94. https://doi.org/10.1177/0897190020959175.

MLA (9th ed.) Citation

L, Fay, et al. "Evaluating the Risk of Developing Thrombocytopenia Within Five Days of Continuous Renal Replacement Therapy Initiation in Septic Patients." Journal of Pharmacy Practice, vol. 35, no. 1, 2022, p. 94, https://doi.org/10.1177/0897190020959175.